REQUEST A DEMO
Total
USD $0.00
Search more companies

Abidopharma Pl Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Abidopharma Pl Sp. z o.o. Profile Updated: April 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Abidopharma Pl Sp. z o.o. is an enterprise located in Poland, with the main office in Warsaw. It operates in the Pharmaceutical Preparation Manufacturing industry. Abidopharma Pl Sp. z o.o. was incorporated on January 20, 2006. There are currently 5 (2007) people employed by Abidopharma Pl Sp. z o.o.. There was a net sales revenue increase of 39.09% reported in Abidopharma Pl Sp. z o.o.’s latest financial highlights for 2023. There was a total growth of 77.93% in Abidopharma Pl Sp. z o.o.’s total assets over the same period.

Headquarters
Ul. Popularna 62 A
Warsaw; Mazowieckie; Postal Code: 02-473

Contact Details: Purchase the Abidopharma Pl Sp. z o.o. report to view the information.

Website: http://www.abidopharma.pl

Basic Information
Total Employees:
Purchase the Abidopharma Pl Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Abidopharma Pl Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Abidopharma Pl Sp. z o.o. report to view the information.
Incorporation Date:
January 20, 2006
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
90%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Abidopharma Pl Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
39.09%
Total operating revenue
72.21%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
N/A
Total assets
77.93%
Total equity
4.36%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?